These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33130469)

  • 21. Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Maierhof SK; Schinke C; Cernoch J; Hew L; Bruske LP; Fernandez Vallone V; Fischer K; Stachelscheid H; Huehnchen P; Endres M; Diecke S; Telugu NS; Boehmerle W
    Stem Cell Res; 2023 Dec; 73():103253. PubMed ID: 37984032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of homozygous Na
    Maurer W; Hartmann N; Argyriou L; Sossalla S; Streckfuss-Bömeke K
    Stem Cell Res; 2022 Apr; 60():102677. PubMed ID: 35092938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing.
    Lilianty J; Bateman JF; Lamandé SR
    Stem Cell Res; 2021 Oct; 56():102515. PubMed ID: 34543885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome).
    Wang B; Ren Q; Cui X; Shan W; Guo X; Wang X; Wang J; Li Y; An G
    Stem Cell Res; 2024 Jun; 77():103400. PubMed ID: 38547667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.
    Diouf D; Vitale MR; Zöller JEM; Pineau AM; Klopocki E; Hamann C; Ziegler GC; Vanmierlo T; Van den Hove D; Lesch KP
    Stem Cell Res; 2023 Mar; 67():103038. PubMed ID: 36746102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of Dip2a homozygous knockout murine ES cell line IBMSe001-A-1 via CRISPR/Cas9 technology.
    Yao M; Yang Q; Lian M; Su P; Cui X; Ren T; Wang X; Wu C; Zheng Y
    Stem Cell Res; 2020 May; 45():101778. PubMed ID: 32361465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of homozygous and heterozygous REEP1 knockout induced pluripotent stem cell lines by CRISPR/Cas9 gene editing.
    Korneck M; Leonhardt A; Schöls L; Hauser S
    Stem Cell Res; 2024 Jun; 77():103378. PubMed ID: 38479332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
    Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
    Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR/Cas9.
    Sung JJ; Park S; Choi SH; Kim J; Cho MS; Kim DW
    Stem Cell Res; 2020 Oct; 48():101948. PubMed ID: 32798916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for PTCH1 gene.
    Zu B; Zhang X; You G; Fu Q
    Stem Cell Res; 2021 Oct; 56():102517. PubMed ID: 34509918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of the CRISPR/Cas9-mediated KIF1C knock-out human iPSC line HIHRSi003-A-1.
    Nagel M; Müßig S; Höflinger P; Schöls L; Hauser S; Schüle R
    Stem Cell Res; 2020 Dec; 49():102059. PubMed ID: 33161238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A.
    Kung LHW; Sampurno L; Yammine KM; Graham A; McDonald P; Bateman JF; Shoulders MD; Lamandé SR
    Stem Cell Res; 2020 Oct; 48():101962. PubMed ID: 33002832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a GFP::LMNB1 knockin cell line (CSUi002-A-1) from a dystonia patient-specific iPSC by CRISPR/Cas9 editing.
    Tang Y; Ren J; Li CC
    Stem Cell Res; 2021 Aug; 55():102505. PubMed ID: 34438319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9.
    Ratnavadivel S; Dammeier J; Gaertner A; de Toledo MAS; Zenke M; Gummert J; Bloch Rasmussen T; Klinke N; Jürgens K; Meyer H; Paululat A; Milting H
    Stem Cell Res; 2024 Apr; 76():103354. PubMed ID: 38430734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
    Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
    Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing.
    Nur Patria Y; Lilianty J; Elefanty AG; Stanley EG; Labonne T; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 Jan; 42():101689. PubMed ID: 31884373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a TLR3 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Kim JH
    Stem Cell Res; 2021 Apr; 52():102187. PubMed ID: 33582546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a heterozygous TPM1-E192K knock-in human induced pluripotent stem cell line using CRISPR/Cas9 system.
    Kang JY; Mun D; Chun Y; Kim H; Yun N; Lee SH; Joung B
    Stem Cell Res; 2022 Aug; 63():102878. PubMed ID: 35917600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.